CoChat

The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance

Open access
Yoon, Mee-Sup, Choi, Cheol Soo · 2016 · Experimental & Molecular Medicine
Cited by 53

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Mammalian target of rapamycin (mTOR) controls cell growth and metabolism in response to nutrients, energy, and growth factors. Recent findings have placed the lysosome at the core of mTOR complex 1 (mTORC1) regulation by amino acids. Two parallel pathways, Rag GTPase-Ragulator and Vps34-phospholipase D1 (PLD1), regulate mTOR activation on the lysosome. This review describes the recent advances in understanding amino acid-induced mTOR signaling with a particular focus on the role of mTOR in insulin resistance. The enzyme mTOR plays key roles in the regulation of mammalian cell metabolism and is implicated in nutrient-induced insulin resistance. mTOR (mammalian target of rapamycin) is part of an intricate network of proteins that pass signals from the outside of the cell to intracellular effectors. Mee-Sup Yoon and Cheol Soo Choi from the Gachon University in Korea reviewed the protein complexes mTOR participates in, in particular mTOR complex 1 (mTORC1) and how activation of this complex by amino acids leads to a reduction in insulin signaling. In rats high levels of amino acids have been linked to hyperactive mTORC1 and insulin resistance. A clear picture of all the proteins involved in the regulation of mTOR by amino acids will point to new candidates for therapy of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2015.93

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

Metadata

Authors
Yoon, M.-S., & Choi, C. S.
Venue
Experimental & Molecular Medicine
Published
2016-01-08
Volume
48
Issue
1
Pages
e201-e201
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2232294056
Cited by
53
References
25
FWCI
3.01
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.